|
|
|
|
| LEADER |
00000cam a2200000Ka 4500 |
| 001 |
in00003499852 |
| 005 |
20190407122343.0 |
| 006 |
m o d |
| 007 |
cr bn||||||abp |
| 007 |
cr bn||||||ada |
| 008 |
110718r19991999gw a ob 001 0 eng d |
| 020 |
|
|
|a 9783642599903 (electronic bk.)
|
| 020 |
|
|
|a 3642599907 (electronic bk.)
|
| 020 |
|
|
|z 3540659277 (acid-free paper)
|
| 020 |
|
|
|z 9783540659273 (acid-free paper)
|
| 035 |
|
|
|a (OCoLC)ocn741524373
|
| 035 |
|
|
|a (OCoLC)741524373
|
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d GW5XE
|d OCLCQ
|d OCLCF
|d OCLCQ
|d UtOrBLW
|
| 042 |
|
|
|a dlr
|
| 049 |
|
|
|a TXAM
|
| 050 |
|
4 |
|a RS380
|b .N68 1999
|
| 060 |
|
4 |
|a QV 744
|b N937 1999a
|
| 082 |
0 |
4 |
|a 615/.19
|2 21
|
| 084 |
|
|
|a 44.38
|2 bcl
|
| 245 |
0 |
0 |
|a Novel therapeutics from modern biotechnology :
|b from laboratory to human testing /
|c Dale Oxender, Leonard E. Post, editors.
|
| 250 |
|
|
|a Springer study ed.
|
| 264 |
|
1 |
|a Berlin ;
|a New York :
|b Springer,
|c [1999]
|
| 264 |
|
4 |
|c ©1999
|
| 300 |
|
|
|a 1 online resource (xvii, 248 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "Second printing 1999 (Originally published in the Handbook of experimental pharmacology, volume 137, ISBN 3540650253, 1999)."
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2011
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 505 |
0 |
|
|a Overview of Regulatory Expectations for Introducing Novel Therapies into Clinical Trials -- Preparation of Clinical Trial Supplies of Biopharmaceuticals -- Protein as Drugs: Analysis, Formulation and Delivery -- Strategies for Dealing with the Immunogenicity of Therapeutic Proteins -- Targeted Toxin Hybrid Proteins -- SB 209763 -- A Humanized Monoclonal Antibody for the Prophylaxis and Treatment of Respiratory Syncytial Virus Infection -- Preclinical Development of Antisense Therapeutics -- Formulation and Delivery of Nucleic Acids -- Development of Production and Quality Control Methods of Retroviral Vectors for Human Gene Therapy -- Clinical Systems for the Production of Cells and Tissues for Human Therapy.
|
| 520 |
|
|
|a This volume addresses the particular problems associated with several classes of biotechnology products, and at the same time demonstrates that the principles are the same as in the development of small new chemical entities. The first chapter addresses FDA regulatory expectations for biotech products. The next several chapters discuss general issues common to each class of biotech drug such as proteins, peptides, and nucleic acids. The balance of the chapters deal with specific biotech drugs that have successfully made it into clinical trials. The reviews are written by renowned experts in their fields.
|
| 588 |
|
|
|a Description based on print version record.
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|
| 650 |
1 |
2 |
|a Drug Design.
|
| 650 |
2 |
2 |
|a Biotechnology.
|
| 650 |
2 |
2 |
|a Drug Evaluation.
|
| 650 |
2 |
2 |
|a Technology, Pharmaceutical.
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology.
|2 fast
|0 (OCoLC)fst01060106
|
| 650 |
1 |
7 |
|a Farmacotherapie.
|2 gtt
|
| 650 |
1 |
7 |
|a Farmacie.
|2 gtt
|
| 650 |
1 |
7 |
|a Biotechnologie.
|2 gtt
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Oxender, Dale L.
|
| 700 |
1 |
|
|a Post, Leonard E.,
|d 1952-
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 776 |
1 |
8 |
|i Print version:
|w (DLC) 99016259
|w (OCoLC)41547997
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=http://link.springer.com/10.1007/978-3-642-59990-3
|z Connect to the full text of this electronic book
|t 0
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 7ea819df-cda5-38a5-80ac-f101260a5690
|i b7a6f128-48a2-36ab-9c9f-65aae1f9a580
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e RS380 .N68 1999
|h Library of Congress classification
|
| 998 |
f |
f |
|a RS380 .N68 1999
|t 0
|l Available Online
|